Search Results

There are 6283 results for: content related to: Dopamine-transporter levels drive striatal responses to apomorphine in P arkinson's disease

  1. You have free access to this content
    The pharmacology and clinical pharmacokinetics of apomorphine SL

    BJU International

    Volume 88, Issue s3, October 2001, Pages: 18–21, A. Argiolas and H. Hedlund

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1464-4096.2001.00124.x

  2. You have free access to this content
    Effects in vitro and in vivo by apomorphine in the rat corpus cavernosum

    British Journal of Pharmacology

    Volume 146, Issue 2, September 2005, Pages: 259–267, Kenshi Matsumoto, Masaki Yoshida, Karl-Erik Andersson and Petter Hedlund

    Version of Record online : 30 JAN 2009, DOI: 10.1038/sj.bjp.0706317

  3. You have free access to this content
    Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus

    Journal of Neurochemistry

    Volume 77, Issue 3, May 2001, Pages: 762–775, Raúl Martín-Ruiz, Luisa Ugedo, María A. Honrubia, Guadalupe Mengod and Francesc Artigas

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1471-4159.2001.00275.x

  4. You have free access to this content
    Safety and tolerability of apomorphine SL in patients with erectile dysfunction

    BJU International

    Volume 88, Issue s3, October 2001, Pages: 30–35, J. Buvat and F. Montorsi

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1464-4096.2001.00127.x

  5. You have free access to this content
    Dopamine D3 receptor stimulation promotes the proliferation of cells derived from the post-natal subventricular zone

    Journal of Neurochemistry

    Volume 91, Issue 6, December 2004, Pages: 1292–1301, V. Coronas, K. Bantubungi, J. Fombonne, S. Krantic, S. N. Schiffmann and M. Roger

    Version of Record online : 4 NOV 2004, DOI: 10.1111/j.1471-4159.2004.02823.x

  6. You have free access to this content
    Activation of D2-like receptors induces sympathetic climactic-like responses in male and female anaesthetised rats

    British Journal of Pharmacology

    Volume 148, Issue 4, June 2006, Pages: 510–516, S A Stafford and J H Coote

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706763

  7. Apomorphine-induced modulation of neural activities in the ventrolateral striatum of rats

    Synapse

    Volume 67, Issue 7, July 2013, Pages: 363–373, Satoshi Fujita, Risako Kato, Yilong Cui, Masanori Terakado, Kurando Suga, Noriaki Koshikawa and Masayuki Kobayashi

    Version of Record online : 7 MAR 2013, DOI: 10.1002/syn.21644

  8. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  9. Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery

    Journal of Pharmaceutical Sciences

    Volume 98, Issue 10, October 2009, Pages: 3735–3747, Tsong-Long Hwang, Yin-Ku Lin, Chen-Hsien Chi, Tse-Hung Huang and Jia-You Fang

    Version of Record online : 20 JAN 2009, DOI: 10.1002/jps.21687

  10. You have free access to this content
    Efficacy of apomorphine SL in erectile dysfunction

    BJU International

    Volume 88, Issue s3, October 2001, Pages: 25–29, V.G. Mirone and C.G. Stief

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1464-4096.2001.00126.x

  11. Dopaminergic regulation of orexin neurons

    European Journal of Neuroscience

    Volume 21, Issue 11, June 2005, Pages: 2993–3001, Michael Bubser, Jim R. Fadel, Lela L. Jackson, James H. Meador-Woodruff, Deqiang Jing and Ariel Y. Deutch

    Version of Record online : 24 JUN 2005, DOI: 10.1111/j.1460-9568.2005.04121.x

  12. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 642–650, Susan H. Fox, Brian Henry, Micheal P. Hill, David Peggs, Alan R. Crossman and Jonathan M. Brotchie

    Version of Record online : 16 JUL 2001, DOI: 10.1002/mds.1148

  13. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  14. Oral apomorphine delivery from solid lipid nanoparticleswith different monostearate emulsifiers: Pharmacokinetic and behavioral evaluations

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 547–557, Ming-Jun Tsai, Yaw-Bin Huang, Pao-Chu Wu, Yaw-Syan Fu, Yao-Ren Kao, Jia-You Fang and Yi-Hung Tsai

    Version of Record online : 25 AUG 2010, DOI: 10.1002/jps.22285

  15. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial

    Movement Disorders

    Volume 22, Issue 16, 15 December 2007, Pages: 2359–2364, Carmine Vitale, Stefano Marconi, Luigi Di Maio, Giuseppe De Michele, Katia Longo, Vincenzo Bonavita and Paolo Barone

    Version of Record online : 25 SEP 2007, DOI: 10.1002/mds.21718

  16. Diagnostic and therapeutic value of apomorphine in Parkinsonian patients

    International Journal of Clinical Practice

    Volume 58, Issue 11, November 2004, Pages: 1028–1032, J.C. Sharma, 1 L. Macnamara, 1 M. Hasoon and 1 M. Vassallo 2

    Version of Record online : 24 NOV 2004, DOI: 10.1111/j.1368-5031.2004.00357.x

  17. You have free access to this content
    Examination of the safety and use of apomorphine prescribed in general practice in England as a treatment for erectile dysfunction

    BJU International

    Volume 98, Issue 1, July 2006, Pages: 125–131, KARYN M. MACLENNAN, ANDREW BOSHIER, LYNDA V. WILTON and SAAD A.W. SHAKIR

    Version of Record online : 8 JUN 2006, DOI: 10.1111/j.1464-410X.2006.06253.x

  18. Morphological and Biochemical Evidence that Apomorphine Rescues Striatal Dopamine Terminals and Prevents Methamphetamine Toxicity

    Annals of the New York Academy of Sciences

    Volume 965, Issue 1, June 2002, Pages: 254–266, G. BATTAGLIA, M. GESI, P. LENZI, C. L. BUSCETI, P. SOLDANI, F. ORZI, L. RAMPELLO, F. NICOLETTI, S. RUGGIERI and F. FORNAI

    Version of Record online : 24 JAN 2006, DOI: 10.1111/j.1749-6632.2002.tb04167.x

  19. Transdermal apomorphine permeation from microemulsions: A new treatment in Parkinson's disease

    Movement Disorders

    Volume 19, Issue 8, August 2004, Pages: 937–942, Lorenzo Priano, Gianni Albani, Andrea Brioschi, Sara Calderoni, Leonardo Lopiano, Mario Rizzone, Roberta Cavalli, Maria Rosa Gasco, Francesco Scaglione, Franco Fraschini, Bruno Bergamasco and Alessandro Mauro

    Version of Record online : 16 MAR 2004, DOI: 10.1002/mds.20054

  20. You have full text access to this OnlineOpen article
    Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease

    Movement Disorders Clinical Practice

    Volume 4, Issue 1, January/February 2017, Pages: 78–83, Stuart Isaacson, Mark Lew, William Ondo, Jean Hubble, Thomas Clinch and Fernando Pagan

    Version of Record online : 25 MAY 2016, DOI: 10.1002/mdc3.12350